The follow-up information is generally not included in these reports, and mortality rates may be underestimated
Other side effects can include dyspepsia, dizziness, abdominal distension, eructation, hypoglycemia, flatulence, gastroenteritis and gastroesophageal reflux disease
Gallbladder Disease and GLP-1 Medication Safety Patients with pre-existing gallbladder disease face higher risk when starting semaglutide because inflammation, stones, or scar tissue already compromise biliary function
Major guidelines treat both drugs as front-line options
The biggest one
To stay competitive with its rival, Wegovy has been launched in FlexiPen format, a convenient, ready-to-use injector, rather than traditional vials